TrueBlue, Inc.(TBI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,210 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
TBI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for TrueBlue, Inc. (TBI), a Industrials sector company. 13F Pro's AI-powered ranking engine scores TBI at 34.1/100 on a 32-signal composite quality model, placing it at rank #2,210 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (10.5) and revenue growth (16.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), TrueBlue, Inc. reports quarterly revenue of $398.6M, net income of $-19.8M, an operating margin of -4.5%. Top institutional holders of TBI by reported 13-F value include Boston Partners, PZENA INVESTMENT MANAGEMENT, BlackRock,, based on the most recent SEC filings. TBI trades on the NYSE exchange and files with the SEC under CIK 768899. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TBI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TrueBlue, Inc. directly from SEC EDGAR. TrueBlue, Inc.'s 13F Pro composite quality score has ranged between 8 and 40 since 2026, currently 34.1 — an improving long-term trajectory across 36 quarterly and live scoring snapshots.
Revenue
Q1 2026
$398.6M
Net Income
Q1 2026
$-19.8M
Free Cash Flow
Q1 2026
$-12.6M
Operating Margin
Q1 2026
-4.5%
D/E Ratio
Q1 2026
0.29
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-25.7% YoYNet Income
-177.8% YoYOperating Income
-168.1% YoYEPS (Diluted)
-192.5% YoYTotal Assets
-38.2% YoYTotal Debt
Op. Cash Flow
-384.0% YoY| Metric | FY 2025 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $1.62B -25.7% | $2.17B +17.7% | $1.85B -22.1% | $2.37B -5.2% | $2.50B -0.4% | $2.51B |
| Net Income | $-48.0M -177.8% | $61.6M +143.5% | $-141.8M -324.9% | $63.1M -4.1% | $65.8M +18.6% | $55.5M |
| Operating Income | $-46.6M -168.1% | $68.4M +139.1% | $-174.9M -364.3% | $66.2M -10.5% | $73.9M -4.7% | $77.6M |
| EPS (Diluted) | $-1.61 -192.5% | $1.74 +143.4% | $-4.01 -349.1% | $1.61 -1.2% | $1.63 +21.6% | $1.34 |
| Total Assets | $638.7M -38.2% | $1.03B +5.4% | $980.6M -13.7% | $1.14B +1.9% | $1.11B +0.5% | $1.11B |
| Total Debt | $65.8M | $0.00 | $0.00 -100.0% | $37.1M -53.6% | $80.0M -32.6% | $118.8M |
| Operating Cash Flow | $-58.0M -384.0% | $20.4M -86.6% | $152.5M +63.1% | $93.5M -25.6% | $125.7M +25.5% | $100.1M |
AI Insight: TBI Ratio Trends
TrueBlue remains unprofitable across all metrics with operating margins deteriorating to -4.5% in Q1 2026 from near-breakeven in Q3 2025.
• Operating margin collapsed from -0.0% in Q3 2025 to -7.0% in Q4 2025, then improved to -4.5% in Q1 2026.
• ROE volatility extreme, swinging from -0.2% in Q2 2025 to -45.9% in Q4 2025 before recovering to -30.9% in Q1 2026.
• Debt-to-equity ratio steadily increased from 0.02 in Q4 2024 to 0.29 in Q1 2026.
⚠ Q4 2025 saw sharp profitability deterioration across all metrics — monitor if this was seasonal or structural.
⚠ Company briefly approached breakeven in Q2-Q3 2025 — track whether this operational improvement can be sustained.
Get alerted when TBI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for TrueBlue, Inc. including:
Top Institutional Holders of TBI
Boston Partners
$12.8M3,267,392 shPZENA INVESTMENT MANAGEMENT LLC
$11.2M2,871,630 shBlackRock, Inc.
$8.4M2,157,845 shROYCE & ASSOCIATES LP
$8.3M2,112,810 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$6.7M1,719,933 shHOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
$5.6M1,430,215 shVANGUARD CAPITAL MANAGEMENT LLC
$4.9M1,242,872 shAzarias Capital Management, L.P.
$3.9M1,001,950 shDIMENSIONAL FUND ADVISORS LP
$3.8M979,203 shRussell Investments Group, Ltd.
$3.3M838,274 sh
| Fund | Value | Shares |
|---|---|---|
| Boston Partners | $12.8M | 3,267,392 |
| PZENA INVESTMENT MANAGEMENT LLC | $11.2M | 2,871,630 |
| BlackRock, Inc. | $8.4M | 2,157,845 |
| ROYCE & ASSOCIATES LP | $8.3M | 2,112,810 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.7M | 1,719,933 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $5.6M | 1,430,215 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.9M | 1,242,872 |
| Azarias Capital Management, L.P. | $3.9M | 1,001,950 |
| DIMENSIONAL FUND ADVISORS LP | $3.8M | 979,203 |
| Russell Investments Group, Ltd. | $3.3M | 838,274 |
More Industrials Companies
View all Industrials →Put TBI on your watchlist
Track score changes the day TrueBlue, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TBI a good stock to buy?
13F Pro's AI-powered analysis of TrueBlue, Inc. (TBI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TBI are available on the TBI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own TBI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TBI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TrueBlue, Inc.'s investment landscape.